SCHEMBL8266187

SCHEMBL8266187

COc1cccc(N(C(=O)c2cnc(N3CCCCC3)nc2C2=C(F)CCC=C2)C(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 4/20 0.35
▸ CHRNA1 P02708 1/20 0.35
▸ CHRNG P07510 1/20 0.35
▸ CHRNB1 P11230 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ CHRNB4 P30926 1/20 0.35
▸ CHRNA3 P32297 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ CHRND Q07001 1/20 0.35
▸ FFAR1 O14842 1/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ USP2 O75604 6/20 0.34
▸ CASP1 P29466 6/20 0.34
▸ CASP7 P55210 6/20 0.34
▸ CYP3A4 P08684 5/20 0.34
▸ HIF1A Q16665 5/20 0.34
▸ CYP2C19 P33261 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923253 0.85 MAPT (0.40) MAPTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL8268303 0.82 PTPN11 (0.40) HTR2CHSD17B10
SCHEMBL8265891 0.82 CYP1A2 (0.38) MAPK1ALDH1A1USP2CASP1CASP7
SCHEMBL8267735 0.81 POLB (0.36) CASP1LMNAPOLBSMN1; SMN2
SCHEMBL8267721 0.81 PIK3R1 (0.35) ALDH1A1USP2CASP1CASP7CYP3A4
SCHEMBL8267731 0.81 GPBAR1 (0.43) MAPTCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL8267809 0.78 MAPT (0.39) MAPTMAPK1CYP3A4CYP2C19LMNA
SCHEMBL8267717 0.78 HTR2C (0.47) MAPK1ALDH1A1USP2CASP1CASP7
SCHEMBL11923270 0.77 WDR5 (0.43) MAPK1FFAR1ALDH1A1USP2CASP1
SCHEMBL8267321 0.77 TACR1 (0.37) MAPTMAPK1ALDH1A1USP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 — — WO disclosed
Send feedback